Dapagliflozin in Heart Failure with Reduced Ejection Fraction (HFrEF): A Systematic Review of Its Mechanisms and Clinical Effectiveness. Journal of Pharmaceutical and Sciences, v. 8, n. 4, p. 2339–2347, 27 Oct.2025.